cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Pacira Pharmaceuticals Inc
4 watching
Current Price
$0
$0.63
(1.6%)
logo-pcrx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,801.09M
52-Week High
52-Week High
82.16
52-Week Low
52-Week Low
35.35
Average Volume
Average Volume
0.19M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
42.8558
iconMarket Capitalization1,801.09M
icon52-Week High82.16
icon52-Week Low35.35
iconAverage Volume0.19M
iconDividend Yield--
iconP/E Ratio42.8558
What does the Pacira Pharmaceuticals Inc do?
Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and commercializes proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers in the United States. The company develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. Its lead product includes, EXPAREL, a liposome injection of bupivacaine, an amide-type local anesthetic indicated for infiltration into the surgical site to produce postsurgical analgesia. The company also markets DepoCyt(e), a liposomal formulation of the chemotherapeutic agent cytarabine indicated for the intrathecal treatment of lymphomatous meningitis, a life-threatening complication of lymphoma, a cancer of the immune system. Its development pipeline comprises DepoTranexamic Acid, a long-acting local antifibrinolytic agent, which is in Phase II clinical development for the treatment or prevention of excessive blood loss during surgery by preventing the breakdown of a clot; and DepoMeloxicam, a long-acting non-steroidal anti-inflammatory drug, which is in preclinical development for the treatment of acute postsurgical pain. The company was formerly known as Pacira, Inc. and changed its name to Pacira Pharmaceuticals, Inc. in October 2010. Pacira Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Parsippany, New Jersey.
Read More
How much money does Pacira Pharmaceuticals Inc make?
News & Events about Pacira Pharmaceuticals Inc.
Globe Newswire
28days ago
TAMPA, Fla., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 41st Annual J.P. Morgan Healthcare Conference at 3:00 PM PT (6:00PM EST) on Monday, January 9, 2023. Live audio of the event can be accessed by visiting the Events page ...
Benzinga
1month ago
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 70 points on Tuesday. Here are some big stocks recording losses in todays session. read more...
Globe Newswire
1month ago
EXPAREL sales were 99 percent and unit volumes were 104 percent of November 2021TAMPA, Fla., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported preliminary ...
Globe Newswire
2 months ago
TAMPA, Fla., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the following two healthcare conferences: Jefferies London Healthcare Conference on Tuesday, November 15th at 8:00AM GMT (3:00AM ET).34th...
Globe Newswire
8 months ago
TAMPA, Fla., June 02, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the Jefferies Healthcare Conference at 9:00 AM ET on Thursday, June 9, 2022 in New York. Live audio of the event can be accessed by ...
Frequently Asked Questions
Frequently Asked Questions
What is Pacira Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Pacira Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Pacira Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Pacira Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Pacira Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Pacira Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Pacira Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Pacira Pharmaceuticals Inc?
plus_minus_icon
What percentage is Pacira Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Pacira Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.63
(1.6%)
logo-pcrx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc
$1.75
$-0.12 (-6.47 %)
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc.
$29.47
$-0.01 (-0.03 %)
FibroGen Inc
FibroGen Inc
$24.11
$0.51 (2.16 %)
Xencor Inc
Xencor Inc
$34.03
$1.11 (3.39 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc
$1.75
$-0.12 (-6.47 %)
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc.
$29.47
$-0.01 (-0.03 %)
FibroGen Inc
FibroGen Inc
$24.11
$0.51 (2.16 %)
Xencor Inc
Xencor Inc
$34.03
$1.11 (3.39 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00